medroxyprogesterone acetate has been researched along with Milk-Alkali Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horiguchi, K; Ishii, S; Matsumoto, S; Osaki, A; Ozawa, A; Satoh, T; Shibusawa, N; Tomaru, T; Yamada, M; Yuasa-Shibasaki, E | 1 |
Cerchietti, LC; Diament, MJ; Klein, SM; Navigante, A; Peluffo, GD; Ranuncolo, SM; Stillitani, I | 1 |
Kunisue, H; Kurebayashi, J; Shimozuma, K; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, S; Yamamoto, Y | 1 |
Horiuchi, R; Iino, Y; Ishikita, T; Maemura, M; Morishita, Y; Ohwada, S; Sugamata, N; Yokoe, T; Yoshida, M | 1 |
4 other study(ies) available for medroxyprogesterone acetate and Milk-Alkali Syndrome
Article | Year |
---|---|
Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate.
Topics: Adrenal Insufficiency; Adult; Antineoplastic Agents, Hormonal; Female; Humans; Hypercalcemia; Medroxyprogesterone Acetate; Withholding Treatment | 2018 |
Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Cachexia; Enzyme-Linked Immunosorbent Assay; Female; Hypercalcemia; Indomethacin; Interleukin-1; Interleukin-6; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Paraneoplastic Syndromes | 2006 |
[A case of advanced breast cancer associated with humoral hypercalcemia that responded to medroxyprogesterone acetate and docetaxel].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Hypercalcemia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Paclitaxel; Taxoids | 2000 |
1 alpha-hydroxyvitamin D3, hypercalcemia, and growth suppression of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Female; Fluorouracil; Hydroxycholecalciferols; Hypercalcemia; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Rats; Rats, Sprague-Dawley; Weight Loss | 1992 |